Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/26 16:08 | 2/10/26 | SGMT | Health | Drug | Pharmaceutical Preparations | Happel David | CA | DO | P,CEO | 2 | S | -663 | 8.55 | 0 | -78 | 690 | D | |||||||||||||||
2/12/26 16:07 | 2/10/26 | SGMT | Health | Drug | Pharmaceutical Preparations | Chauche Thierry | CA | O | CFO | 1 | S | -7 | 5.36 | 0 | -1 | 16 | D | |||||||||||||||
2/12/26 16:06 | 2/10/26 | SGMT | Health | Drug | Pharmaceutical Preparations | Martins Eduardo Bruno | CA | O | Chief Me | 2 | S | -95 | 7.98 | 0 | -12 | 107 | D | |||||||||||||||
2/12/26 16:05 | 2/10/26 | SGMT | Health | Drug | Pharmaceutical Preparations | Rozek Elizabeth | CA | O | Chief Le | 2 | S | -113 | 8.40 | 0 | -13 | 191 | D | |||||||||||||||
11/21/25 18:13 | 11/20/25 | SGMT | Health | Drug | Pharmaceutical Preparations | Kemble George | CA | DO | Exec CB | 1 | S | -290 | 7.69 | 0 | -38 | 81 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |